Camber Pharmaceuticals adds 500 count to Generic Zetia®

Piscataway, NJ, July 18, 2024 – Camber Pharmaceuticals is pleased to announce the addition of Ezetimibe 500 count to its product line.
Last August, Camber launched the 10 mg of Ezetimibe Tablets in 30 and 90 count bottles.
Ezetimibe 10 mg Tablets are now available in 30, 90 and 500 count bottles.
To find out more about Ezetimibe Tablets, USP please visit www.camberpharma.com.
Recent articles
- Camber Launches Temozolomide Capsules, USP
- Camber Launches Eltrombopag Tablets & Oral Suspension
- Camber Launches Eslicarbazepine Acetate Tablets
- Camber Launches Phenylephrine Hydrochloride Injection, USP
- Camber Launches Chlorzoxazone Tablets, USP
- Camber Launches 13 New Generic Products in Q1 2025, Sets Ambitious Pace for the Year